Amneal Pharmaceuticals Hits Day High with Strong 7.15% Intraday Surge

Amneal Pharmaceuticals, Inc. has experienced a significant uptick in its stock performance, gaining 7.15% on June 9, 2026. The stock reached an intraday high of USD 14.73, reflecting a strong day of trading for the small-cap pharmaceutical company. Over the past week, Amneal has surged by 16.13%, significantly outperforming the S&P 500, which declined by 2.93% during the same period. In terms of longer-term performance, Amneal has shown impressive growth, with a remarkable 93.04% increase over the past year, compared to the S&P 500's 22.99%. The company's year-to-date performance stands at 16.59%, again surpassing the broader market's 7.91%. Notably, Amneal's three-year performance has skyrocketed by 502.05%, indicating a strong recovery and growth trajectory. Despite these positive indicators, the company faces challenges, including a negative book value and a weak long-term fundamental strength. However, it has reported outstanding results in recent quarters, with a net profit growth of 410.5% and a high interest coverage ratio of 348.68. With institutional holdings at 59.47%, Amneal Pharmaceuticals continues to navigate a complex market landscape while delivering consistent returns.